Delivery Order SPE2DB22D9239-SPE2DB25FDL67
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $24,179.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count). The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units) valued at $72,538.74. This firm fixed-price delivery order, awarded on September 18, 2025, with completion targeted for September 19, 2025, represents a tactical fulfillment under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA. The vendor...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,146.79 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Jakafi 5 mg tablets (60-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and was awarded without set-aside designation. This delivery order is issued under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count). The contract is valued at approximately $24.2K with a firm fixed-price structure and an ultimate completion date of September 17, 2025. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500M through...
- The Defense Logistics Agency awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,999.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The award carries no set-aside designation and represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 6, 2025, is due for completion by August 7, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing under its larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on April 22, 2025, for the supply of Jakafi 10 mg tablets (60-count). The order, which carries no set-aside designation, is scheduled for completion by April 23, 2025, and will be performed at the vendor's Park Ridge location. This delivery order is issued under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $24,179.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). The contract, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL67Delivery Order
The Defense Logistics Agency awarded a $60,733.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 master agreement valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, specializing in the distribution of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's contract portfolio demonstrates extensive experience supplying specialized pharmaceutical products ranging from oncology treatments to vaccines and contraceptive devices. As a woman-owned small business registered in SAM.gov since 2001, the company leverages its status to compete effectively in federal procurement markets while maintaining consistent delivery performance across diverse pharmaceutical product categories supporting military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.7k | 9/9/25 |